Immunotherapy in Advanced NSCLC Without Driver Mutations: Available Therapeutic Alternatives After Progression and Future Treatment Options. Leal JL, John T. Clin Lung Cancer 2022;23:643-658.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leal JL, John T. Immunotherapy in Advanced NSCLC Without Driver Mutations: Available Therapeutic Alternatives After Progression and Future Treatment Options. Clin Lung Cancer 2022;23:643-658.
PMID: 36130865